Holmes Defends Theranos' 'Aggressive' IP Protection At Trial
By Dorothy Atkins · December 7, 2021, 11:15 PM EST
Ex-Theranos CEO Elizabeth Holmes' cross-examination in her criminal fraud trial wrapped Tuesday, with Holmes conceding that she didn't tell investors Theranos was performing blood tests on modified third-party devices but defending...
To view the full article, register now.